An assessment model for efficacy of autologous CD19 chimeric antigen receptor T-cell therapy and relapse or refractory diffuse large B-cell lymphoma risk

被引：0
|
作者：
Xue, Bin [1 ]
Liu, Yifan [1 ]
Zhang, Min [1 ]
Xiao, Gangfeng [1 ,2 ]
Luo, Xiu [1 ]
Zhou, Lili [1 ]
Ye, Shiguang [1 ]
Lu, Yan [1 ]
Qian, Wenbin [3 ]
Wang, Li [4 ]
Li, Ping [1 ]
Liang, Aibin [1 ]
机构：
[1] Tongji Univ, Sch Med, Shanghai Tongji Hosp, Dept Hematol, Shanghai 200065, Peoples R China
[2] Ningbo No 2 Hosp, Dept Hematol, Ningbo 315010, Zhejiang, Peoples R China
[3] Zhejiang Univ, Affiliated Hosp 2, Coll Med, Dept Hematol, Hangzhou 310009, Zhejiang, Peoples R China
[4] Shanghai Jiao Tong Univ, Ruijin Hosp, Sch Med, Dept Hematol, Shanghai 200001, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2025年 / 138卷 / 01期
基金：
国家重点研发计划; 上海市自然科学基金; 中国国家自然科学基金;
关键词：
D O I：
10.1097/CM9.0000000000003343
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：108 / 110
页数：3
相关论文
共 50 条
  • [21] High pretreatment disease burden as a risk factor for infectious complications following CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma
    O'Reilly, Maeve A.
    Neill, Lorna
    Collin, Simon M.
    Stone, Neil
    Springell, Deborah
    Mensah, Jeremy
    Cheok, Kathleen P. L.
    Jalowiec, Katarzyna
    Benjamin, Reuben
    Kuhnl, Andrea
    Roddie, Claire
    Sanderson, Robin
    HEMASPHERE, 2024, 8 (01):
  • [22] How to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B-cell lymphoma?
    de Ramon Ortiz, Carmen
    Wang, Sisi
    Stathis, Anastasios
    Bertoni, Francesco
    Zenz, Thorsten
    Novak, Urban
    Simonetta, Federico
    HEMATOLOGICAL ONCOLOGY, 2024, 42 (01)
  • [23] Autologous CD19-directed chimeric antigen receptor-T cell is an effective and safe treatment to refractory or relapsed diffuse large B-cell lymphoma
    Fang Bao
    Wei Wan
    Ting He
    Feifei Qi
    Guanghua Liu
    Kai Hu
    Xin-an Lu
    Ping Yang
    Fei Dong
    Jing Wang
    Hongmei Jing
    Cancer Gene Therapy, 2019, 26 : 248 - 255
  • [24] Autologous CD19-directed chimeric antigen receptor-T cell is an effective and safe treatment to refractory or relapsed diffuse large B-cell lymphoma
    Bao, Fang
    Wan, Wei
    He, Ting
    Qi, Feifei
    Liu, Guanghua
    Hu, Kai
    Lu, Xin-an
    Yang, Ping
    Dong, Fei
    Wang, Jing
    Jing, Hongmei
    CANCER GENE THERAPY, 2019, 26 (7-8) : 248 - 255
  • [25] Efficacy and safety of chimeric antigen receptor T cell therapy combined with zanubrutinib in the treatment of relapsed/refractory diffuse large B-cell lymphoma
    Wang, Langqi
    Yue, Chunyan
    Zhou, Xuan
    Yang, Jilong
    Jin, Bo
    Wang, Bo
    Huang, Minhong
    Chen, Huifang
    Zhou, Lijuan
    Tu, Sanfang
    Li, Yuhua
    CHINESE MEDICAL JOURNAL, 2025, 138 (06) : 748 - 750
  • [26] Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma
    Strati, Paolo
    Ahmed, Sairah
    Furqan, Fateeha
    Fayad, Luis E.
    Lee, Hun J.
    Iyer, Swaminathan P.
    Nair, Ranjit
    Nastoupil, Loretta J.
    Parmar, Simrit
    Rodriguez, Maria A.
    Samaniego, Felipe
    Steiner, Raphael E.
    Wang, Michael
    Pinnix, Chelsea C.
    Horowitz, Sandra B.
    Feng, Lei
    Sun, Ryan
    Claussen, Catherine M.
    Hawkins, Misha C.
    Johnson, Nicole A.
    Singh, Prachee
    Mistry, Haleigh
    Johncy, Swapna
    Adkins, Sherry
    Kebriaei, Partow
    Shpall, Elizabeth J.
    Green, Michael R.
    Flowers, Christopher R.
    Westin, Jason
    Neelapu, Sattva S.
    BLOOD, 2021, 137 (23) : 3272 - 3276
  • [27] Efficacy and Safety of Autologous Stem Cell Transplantation Combined with Chimeric Antigen Receptor T-Cell Therapy in the Treatment of Refractory/Relapsed B-Cell Lymphoma
    Ma, Lixia
    Ke, Xiaoyan
    Hu, Kai
    BLOOD, 2023, 142
  • [28] Current development of chimeric antigen receptor T-cell therapy for diffuse large B-cell lymphoma and high-grade B-cell lymphoma
    Yamauchi, Nobuhiko
    Maruyama, Dai
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2024, 112 (05) : 662 - 677
  • [29] RE: Epigenetic profiling and response to CD19 chimeric antigen receptor T-cell therapy in B-cell malignancies
    Lee, Hwan Young
    Yang, Soo-Bin
    Park, Mi Young
    Baek, Gyung Won
    Kang, Hyoung Jin
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2023, 115 (10): : 1231 - 1233
  • [30] Radiation Priming Chimeric Antigen Receptor T-Cell Therapy in Relapsed/Refractory Diffuse Large B-Cell Lymphoma With High Tumor Burden
    Qu, Changju
    Ping, Nana
    Kang, Liqing
    Liu, Hailing
    Qin, Songbin
    Wu, Qian
    Chen, Xiaochen
    Zhou, Meng
    Xia, Fan
    Ye, Aihua
    Kong, Danqing
    Li, Caixia
    Yu, Lei
    Wu, Depei
    Jin, Zhengming
    JOURNAL OF IMMUNOTHERAPY, 2020, 43 (01) : 32 - 37
12345